These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10652184)

  • 1. Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998.
    Milstien JB; Zaffran M; Wood DJ; Griffiths E
    Biologicals; 1999 Sep; 27(3):277-8. PubMed ID: 10652184
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
    Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
    Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impotency of live-virus vaccines as a result of improper handling in clinical practice.
    Krugman RD; Meyer BC; Enterline JC; Parkman PD; Witte JJ; Meyer HM
    J Pediatr; 1974 Oct; 85(4):512-4. PubMed ID: 4443859
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 910():1-104, back cover. PubMed ID: 15497598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on new attenuated strains of type I live poliovirus vaccine. I. Development of Zhong I9 strain].
    Chen TQ; Li CZ; Ni SF; Ji GF; Shi M; Ye ZZ; Guo R; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct; 5(5):280-4. PubMed ID: 6329533
    [No Abstract]   [Full Text] [Related]  

  • 8. Potency test of inactivated polio vaccines in guinea pigs.
    Lapinleimu K; Stenvik M
    Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration. Tempest over polio vaccine.
    Anderson C
    Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758
    [No Abstract]   [Full Text] [Related]  

  • 11. The standardization of vaccines: a discussion.
    Perkins FT
    Rev Infect Dis; 1984; 6 Suppl 2():S523-4. PubMed ID: 6740098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Temperature stability of poliovirus vaccine of attenuated virus produced in the Instituto Nacional de Virología].
    Kado Boll G; Barrón I; de la Sierra L
    Salud Publica Mex; 1979; 21(3):263-9. PubMed ID: 550306
    [No Abstract]   [Full Text] [Related]  

  • 15. International workshop: 'poliovirus attenuation: molecular mechanisms and practical aspects'. 9-10 December 1991, Holiday Inn, Bethesda, MD, U.S.A.
    Ehrenfeld E
    Biologicals; 1992 Jun; 20(2):167-9. PubMed ID: 1327006
    [No Abstract]   [Full Text] [Related]  

  • 16. Killed poliovaccine: an evaluation of safety testing.
    van Steenis G; van Wezel AL
    Dev Biol Stand; 1981; 47():143-50. PubMed ID: 6262145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations of the incidence of structural abnormalities in the chromosomes of WI-38 cells prepared for vaccine manufacture.
    Allnutt BJ; Purnell DJ; Roberts B
    Dev Biol Stand; 1976 Dec 13-15; 37():177-80. PubMed ID: 1031683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents.
    Kops SP
    Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage of poliovirus vaccine.
    Chao J
    Am Fam Physician; 1991 Sep; 44(3):756, 758. PubMed ID: 1877422
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of viral vaccines; poliovaccines as a model.
    Tagaya I
    Jpn J Med Sci Biol; 1968 Aug; 21(4):296-7. PubMed ID: 5304277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.